Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

San Diego, USA
12481 High Bluff Drive
Suite 150
San Diego, CA, 92130
USA

People

CMO
CFO
Chief Business Officer
Board Observer

Funding

TOTAL $38M
FUNDING TOTAL $38M
Series A, 1/2008
Domain Associates
Scale Venture Partners
Alta Partners
AgeChem Venture Fund
Mitsubishi Corporation Life Sciences Venture
$30M
Series A, 4/2010
$7M
Partial Close, 10/2011
$1M
DEBT TOTAL $3.22M
Debt, 4/2012
$1.22M
Debt, 8/2012
$2M

Tags

Sonexa Therapeutics

Sonexa Therapeutics, Inc., a pharmaceutical company, engages in the development of therapeutics drugs for the treatment of Alzheimer’s disease and related disorders. It develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier. The company was incorporated in 2007 and is based in San Diego, California.

Recent Milestones

Videos

Screenshots

Sonexa Therapeutics screenshot
Above: Homepage
Uploaded: 9/24/13

Sources

  1. Sonexa Therapeutics, Inc. Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments (biospace.com) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
Edit This Page
Last Edited 4/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy